NOVA-OX Tabs -Export concentrate Dutrion Tablet Safety Data Sheet
according to the REACH Regulation (EC) 1907/2006 amended by Regulation (EU) 2020/878 Issue date: 6/7/2021 Version: 1.0
SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product form Product name UFI Product group
: : : :
Mixture Concentrate Dutrion Tablet NOVA-OX tabsExport 7QH5-202K-A009-PJWN Trade product
1.2. Relevant identified uses of the substance or mixture and uses advised against 1.2.1. Relevant identified uses Main use category Use of the substance/mixture
: Professional use : Disinfectant antiseptic
Title
Life cycle stage
Use descriptors
Dutrion Tablet NOVA-OX tabsExport
Professional
PC37
Full text of use descriptors: see section 16 1.2.2. Uses advised against No additional information available
1.3. Details of the supplier of the safety data sheet Duka Production NAC Europe ApSBV Pieter Bruegelstraat 1 Ellegårdvej 18 DK-6400 NL– 7731Sønderborg SK Ommen DENMARK The Netherlands E-mail: info@nac-europe.com T +31 (529) 712520 Tel.: +45 7442 6292 info@dutrion.com - www.dutrion.com
1.4. Emergency telephone number Country
Official advisory body
Address
Emergency number
United Kingdom
National Poisons Information Service (Birmingham Centre) City Hospital
Dudley Road B18 7QH Birmingham
0344 892 0111
Comment
SECTION 2: Hazards identification 2.1. Classification of the substance or mixture Classification according to Regulation (EC) No. 1272/2008 [CLP] Oxidising Solids, Category 1
H271
Acute toxicity (oral), Category 4
H302
Acute toxicity (dermal), Category 3
H311
Skin corrosion/irritation, Category 1, Sub-Category 1B
H314
Serious eye damage/eye irritation, Category 1
H318
Specific target organ toxicity — Repeated exposure, Category 2
H373
Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available
6/7/2021 (Issue date)
EN (English)
1/15